Cyagen Biosciences
PrivateLast Round
Series B
Feb 26, 2020
Total Funding Raised
$40.6M
Company Overview
Cyagen Biosciences operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Series B round in February 2020.
Cyagen Biosciences is a biotechnology company that provides genetically modified rodent models and contract research organization (CRO) solutions for biomedical research and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyagen Biosciences Comparables
Compare Cyagen Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ingenious Targeting Laboratory | 85% | |
| Genoway | 85% | |
| GemPharmatech | 85% |
For institutional investors. Book with your work email.
Cyagen Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 26, 2020 | ||||
| Series A | Aug 11, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cyagen Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GF Xinde Investment Management | Series B |
| China Merchants Zhiyuan Capital Investment Co., Ltd. | Series B |
| LYFE Capital | Series A |
| Grower Venture Capital | Series B |
| GF Qianhe Investment Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 7, 2025
Monthly visitors increased 48% MoM.
- May 2, 2025
Monthly visitors increased 91% MoM to 58.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 12, 2026
Cyagen introduces IgScope, an AI-powered antibody language model that assesses antibody humanness at the full-chain, regional, and individual amino acid levels, in China on Oct 30th '26.
- is_developingNov 2, 2026
Cyagen and a Tsinghua research team develop PPBind-3D/1D, which integrates structure- and sequence-based AI models for high-throughput affinity ranking and virtual screening in antibody and protein drug discovery, in China on Oct 13th '26.
For institutional investors. Book with your work email.
Cyagen Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cyagen Biosciences's valuation, stock price, and market status.
Is Cyagen Biosciences a public or private company?
Cyagen Biosciences is a private company.
What is the current stock price of Cyagen Biosciences?
Cyagen Biosciences is a private company, so its shares have no public market price. Caplight tracks Cyagen Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cyagen Biosciences worth (valuation)?
Valuation information for Cyagen Biosciences is not publicly available.
Can I buy Cyagen Biosciences stock?
Cyagen Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cyagen Biosciences's last funding round?
Cyagen Biosciences's most recent funding round was Series B on February 26, 2020.
Who are the main investors in Cyagen Biosciences?
Key investors in Cyagen Biosciences include LYFE Capital.
Will Cyagen Biosciences IPO soon?
No public IPO plans have been announced for Cyagen Biosciences.
How can I track Cyagen Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Cyagen Biosciences's shares on secondary markets.